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Introduction: P2Y1 and P2Y12 receptors belong to the class A family of transmembrane GPCRs that 
are activated by endogenous nucleotides1. There is growing evidence that many GPCRs, including P2Y 
receptors, can exist as dimers or higher-order oligomers2. For example, P2Y12 and PAR4 receptors 
were recently reported to dimerise3. Our previous studies indicated that hP2Y1 and hP2Y12 receptors 
may form a functional heterodimer with novel pharmacological and signalling properties4. The aim of 
this project was, therefore, to characterise the physical interaction between hP2Y1 and hP2Y12 
receptors. 
Method: tSA201 cells were transfected or co-transfected with hP2Y1 and hP2Y12 receptors, tagged 
with HA or a fluorescent protein. Cellular localisation and co-localisation of the receptors were 
determined using confocal microscopy. Transfected cells were cultured in the absence or presence of 
the N-JO\FRV\ODWLRQ LQKLELWRU WXQLFDP\FLQ  ȝJPO IRU  KRXUV WR GHWHUPLQH WKH UROH RI 1-
glycosylation in receptors expression. Receptor cell surface expression was quantified using ELISA. 
To investigate physical interaction between the two P2Y subtypes, co-immunoprecipitation was 
performed using anti-HA-agarose beads followed by immunoblotting with anti-GFP, anti-HA then 
alpha-Tubulin antibodies. 
Result: Following transfection on their own or together, both receptors were localised mainly at the 
cell membrane, and this was unaffected by tunicamycin. Co-immunoprecipitation confirmed that P2Y1 
and P2Y12 receptors associate physically. Each subtype enhanced the other's surface expressions. In 
particular, expression of the P2Y12 receptor more than doubled that of P2Y1 receptors at the cell 
surface. 
Conclusion: These results show that P2Y1 and P2Y12 receptors are physically associated at the cell 
membrane and that they enhance each other's cell surface expressions. These results are consistent with 
our previous data indicating that P2Y1 and P2Y12 receptors form a functional heteromer. 
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